Interestingly, we also saw a decrease of the immune checkpoint ligand PD-L1 expression on macrophages and neutrophils in the tumours (Supplementary Fig. 16) as well as a decrease in the numbers of these immunosuppressive cells in the tumours28 suggesting that miR-103 treatment may modulate the immune microenvironment. The gene discussed is CD274; the disease is neoplasm.